Alzheimer's disease: updated multi-targets therapeutics are in clinical and in progress

Z Sang, K Wang, J Dong, L Tang - European journal of medicinal chemistry, 2022 - Elsevier
Alzheimer's disease is a chronic and progressive brain neurodegenerative disease affecting
over 30 million people globally. Currently, no effective treatment is available due to multiple …

Drugs in clinical trials for Alzheimer's disease: the major trends

SO Bachurin, EV Bovina… - Medicinal research …, 2017 - Wiley Online Library
Alzheimer's disease (AD) is characterized by a chronic and progressive neurodegenerative
process resulting from the intracellular and extracellular accumulation of fibrillary proteins …

Current enlightenment about etiology and pharmacological treatment of autism spectrum disorder

N Eissa, M Al-Houqani, A Sadeq, SK Ojha… - Frontiers in …, 2018 - frontiersin.org
Autistic Spectrum Disorder (ASD) is a complex neurodevelopmental brain disorder
characterized by two core behavioral symptoms, namely impairments in social …

Therapeutics of neurotransmitters in Alzheimer's disease

R Kandimalla, PH Reddy - Journal of Alzheimer's Disease, 2017 - content.iospress.com
Alzheimer's disease (AD) is a progressive neurodegenerative disease, characterized by the
loss of memory, multiple cognitive impairments and changes in the personality and …

The histamine H3 receptor: structure, pharmacology, and function

G Nieto-Alamilla, R Márquez-Gómez… - Molecular …, 2016 - ASPET
Among the four G protein–coupled receptors (H1–H4) identified as mediators of the biologic
effects of histamine, the H3 receptor (H3R) is distinguished for its almost exclusive …

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials

VA Nazarova, AV Sokolov, VN Chubarev… - Frontiers in …, 2022 - frontiersin.org
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders having a high influence on social interactions. The number of …

Role of neuroinflammation in autism spectrum disorder and the emergence of brain histaminergic system. Lessons also for BPSD?

N Eissa, A Sadeq, A Sasse, B Sadek - Frontiers in pharmacology, 2020 - frontiersin.org
Many behavioral and psychological symptoms of dementia (BPSD) share similarities in
executive functioning and communication deficits with those described in several …

Histamine release from mast cells and basophils

F Borriello, R Iannone, G Marone - … and histamine receptors in health and …, 2017 - Springer
Mast cells and basophils represent the most relevant source of histamine in the immune
system. Histamine is stored in cytoplasmic granules along with other amines (eg, serotonin) …

Cognitive deficit in schizophrenia: from etiology to novel treatments

AL Martínez, J Brea, S Rico, MT De los Frailes… - International journal of …, 2021 - mdpi.com
Schizophrenia is a major mental illness characterized by positive and negative symptoms,
and by cognitive deficit. Although cognitive impairment is disabling for patients, it has been …

Mast cell activation: beyond histamine and tryptase

TC Theoharides, AI Perlman, A Twahir… - Expert Review of …, 2023 - Taylor & Francis
Introduction Mast cells are found in all tissues and express numerous surface receptors
allowing them to sense and respond to allergic, autoimmune, environmental …